Results of repeat renal transplantation after graft loss from BK virus nephropathy

Transplantation

Volumn 92, Issue 7, 2011, Pages 781-786

  Geetha, Duvuru ^a   Sozio, Stephen M ^a   Ghanta, Mythili ^b   Josephson, Michelle ^c   Shapiro, Ron ^d   Dadhania, Darshana ^e   Hariharan, Sundaram ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

BK virus; Kidney transplantation; Outcomes; Retransplantation

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; BK VIRUS; BK VIRUS NEPHROPATHY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; FEMALE; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; VIRAL CLEARANCE; VIREMIA; VIRUS REPLICATION;

ADULT; BK VIRUS; CREATININE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR VIRUS INFECTIONS; UNITED STATES; VIRUS REPLICATION;

EID: 81155160150     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822d08c1     Document Type: Review

References (21)

1. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006; 69: 655.
2. Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354.
3. Egli A, Helmersen DS, Taub K, et al. Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy.AmJ Transplant 2010; 10: 2324.
4. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008; 3: S68.
5. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
6. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727.
7. Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: Update of clinical management in kidney transplant patients. Transpl Infect Dis 2006; 8: 76.
8. Dharnidharka VR, Cherikh WS, Neff R, et al. Retransplantation after BK virus nephropathy in prior kidney transplant: An OPTN database analysis. Am J Transplant 2010; 10: 1312.
9. Ramos E, Vincenti F, Lu WX, et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131.
10. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
11. Andrews CA, Shah KV, Daniel RW, et al. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158: 176.
12. Limaye AP, Jerome KR, Kuhr CS, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183: 1669.
13. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
14. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
15. Mindlova M, Boucek P, Saudek F, et al. Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: An effective treatment option in simultaneous pancreas and kidney transplant recipients. Transpl Int 2008; 21: 353.
16. Womer KL, Meier-Kriesche HU, Patton PR, et al. Preemptive retransplantation for BK virus nephropathy: Successful outcome despite active viremia. Am J Transplant 2006; 6: 209.
17. Ziedina I, Folkmane I, Chapenko S, et al. Reactivation of BK virus in the early period after kidney transplantation. Transplant Proc 2009; 41: 766.
18. Li YJ, Chen YC, Lai PC, et al. A direct association of polyomavirus BK viruria with deterioration of renal allograft function in renal transplant patients. Clin Transplant 2009; 23: 505.
19. Hayat A, Mukhopadhyay R, Radhika S, et al. Adverse impact of pretransplant polyoma virus infection on renal allograft function. Nephrology (Carlton) 2008; 13: 157.
20. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
21. Guasch A, Roy-Chaudhury P, Woodle ES, et al. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010; 90: 891.